Profiles

Keywords
Last Name
Institution

Connection

Search Results to Parameswaran Venugopal

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Venugopal, Parameswaran

Item TypeName
Concept Antibodies, Monoclonal, Murine-Derived
Concept Antibodies, Monoclonal
Academic Article Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
Academic Article Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Academic Article Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Academic Article Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma.
Academic Article Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Academic Article Lymphomatoid granulomatosis treated with rituximab and chemotherapy.
Academic Article Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
Academic Article Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Academic Article GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas.
Academic Article Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.
Academic Article Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
Academic Article Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Search Criteria
  • Antibodies Monoclonal